ELUT (Elutia) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 29, 2026)


ELUT Elutia Inc ELUT
37 GF Score
Price $0.96
GF Value $0.91
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Elutia Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Elutia's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

ELUT vs NSYS, MYO, SRTS: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Elutia's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elutia Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elutia's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Elutia's Margin of Safety % (DCF FCF Based) falls into.


ELUT
37GF Score
Elutia Inc ELUT
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Elutia (ELUT) Overvalued in 2026?

Based on GuruFocus' analysis, Elutia stock appears to be overvalued. The current stock price of $0.96 is trading 5.1% above its estimated GF Value™ of $0.91. GuruFocus considers Elutia to be Fairly Valued.

Key valuation signals for ELUT:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $0.91 vs. price of $0.96 (5.1% above fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the ELUT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elutia Business Description

Address 20 Firstfield Road, Gaithersburg, MD, USA, 20878
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
37GF Score

Get the complete analysis for ELUT

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.96
Price
$0.91
GF Value